B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PDE6A

MOLECULAR TARGET

phosphodiesterase 6A

UniProt: P16499NCBI Gene: 51451 compounds

PDE6A (phosphodiesterase 6A) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PDE6A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Antazoline0.691

About PDE6A as a Drug Target

PDE6A (phosphodiesterase 6A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented PDE6A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PDE6A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.